Recurrent and De Novo Toxoplasmosis Retinochoroiditis following Coronavirus Disease 2019 Infection or Vaccination
Abstract
:1. Introduction
2. Methods
3. Results
3.1. Case 1
3.2. Case 2
3.3. Case 3
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Smith, J.R.; Ashander, L.M.; Arruda, S.L.; Cordeiro, C.A.; Lie, S.; Rochet, E.; Belfort, R., Jr.; Furtado, J.M. Pathogenesis of ocular toxoplasmosis. Prog. Retin. Eye Res. 2021, 81, 100882. [Google Scholar] [CrossRef] [PubMed]
- Vishnevskia-Dai, V.; Achiron, A.; Buhbut, O.; Berar, O.V.; Musika, A.A.; Elyashiv, S.M.; Hecht, I. Chorio-retinal toxoplasmosis: Treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center. Int. Ophthalmol. 2020, 40, 811–821. [Google Scholar] [CrossRef] [PubMed]
- Olson, D.J.; Parhiz, A.T.; Wirthlin, R.S. Reactivation of Latent Toxoplasmosis Following Dexamethasone Implant Injection. Ophthalmic Surg. Lasers Imaging Retin. 2016, 47, 1050–1052. [Google Scholar] [CrossRef] [PubMed]
- Puga, M.; Carpio, D.; Sampil, M.; Zamora, M.J.; Fernandez-Salgado, E. Ocular Toxoplasmosis Reactivation in a Patient With Inflammatory Bowel Disease Under Treatment With Azathioprine. J. Clin. Gastroenterol. 2016, 50, 610. [Google Scholar] [CrossRef] [PubMed]
- Zhou, R.; To, K.K.; Wong, Y.C.; Liu, L.; Zhou, B.; Li, X.; Huang, H.; Mo, Y.; Luk, T.Y.; Lau, T.T.; et al. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses. Immunity 2020, 53, 864–877.e5. [Google Scholar] [CrossRef]
- Majtanova, N.; Kriskova, P.; Keri, P.; Fellner, Z.; Majtan, J.; Kolar, P. Herpes Simplex Keratitis in Patients with SARS-CoV-2 Infection: A Series of Five Cases. Medicina 2021, 57, 412. [Google Scholar] [CrossRef]
- Nofal, A.; Fawzy, M.M.; Sharaf ELDeen, S.M.; El-Hawary, E.E. Herpes zoster ophthalmicus in COVID-19 patients. Int. J. Dermatol. 2020, 59, 1545–1546. [Google Scholar] [CrossRef]
- Polack, F.P.; Thomas, S.J.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J.L.; Marc, G.P.; Pérez, G.; Moreira, E.D.; et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 2020, 383, 2603–2615. [Google Scholar] [CrossRef]
- Baden, L.R.; El Sahly, H.M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S.A.; Rouphael, N.; Creech, C.B.; et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021, 384, 403–416. [Google Scholar] [CrossRef]
- Voysey, M.; Clemens, S.A.; Madhi, S.A.; Weckx, L.Y.; Folegatti, P.M.; Aley, P.K.; Angus, B.; Baillie, V.L.; Barnabas, S.L.; Bhorat, Q.E.; et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021, 397, 99–111. [Google Scholar] [CrossRef]
- Amit, S.; Regev-Yochay, G.; Afek, A.; Kreiss, Y.; Leshem, E. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet 2021, 397, 875–877. [Google Scholar] [CrossRef]
- Nordström, P.; Ballin, M.; Nordström, A. Association Between Risk of COVID-19 Infection in Nonimmune Individuals and COVID-19 Immunity in Their Family Members. JAMA Intern. Med. 2021, 181, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Abousy, M.; Bohm, K.; Prescott, C.; Bonsack, J.M.; Rowhani-Farid, A.; Eghrari, A.O. Bilateral EK Rejection After COVID-19 Vaccine. Eye Contact Lens. 2021, 47, 625–628. [Google Scholar] [CrossRef] [PubMed]
- Papasavvas, I.; de Courten, C.; Herbort, C.P. Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination–report of three cases. J. Ophthalmic Inflamm. Infect. 2021, 11, 28. [Google Scholar] [CrossRef]
- Bolletta, E.; Iannetta, D.; Mastrofilippo, V.; De Simone, L.; Gozzi, F.; Croci, S.; Bonacini, M.; Belloni, L.; Zerbini, A.; Adani, C.; et al. Uveitis and Other Ocular Complications Following COVID-19 Vaccination. J. Clin. Med. 2021, 10, 5960. [Google Scholar] [CrossRef]
- Hébert, M.; Buys, Y.M.; Damji, K.F.; Yin, V.T.; Aubin, M.J. Data reporting in ophthalmology during COVID-19 pandemic: Need for a Canadian registry. Can. J. Ophthalmol. 2021, 56, e75–e76. [Google Scholar] [CrossRef]
- Jones, L.A.; Alexander, J.; Roberts, C.W. Ocular toxoplasmosis: In the storm of the eye. Parasite Immunol. 2006, 28, 635–642. [Google Scholar] [CrossRef]
- Rudzinski, M.; Argüelles, C.; Couto, C.; Oubiña, J.R.; Reina, S. Immune Mediators against Toxoplasma Gondii during Reactivation of Toxoplasmic Retinochoroiditis. Ocul. Immunol. Inflamm. 2019, 27, 949–957. [Google Scholar] [CrossRef]
- Sette, A.; Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 2021, 184, 861–880. [Google Scholar] [CrossRef]
- Gajurel, K.; Dhakal, R.; Montoya, J.G. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: A review of the literature and recommendations. Curr. Opin. Infect. Dis. 2015, 28, 283–292. [Google Scholar] [CrossRef]
- Pradhan, E.; Bhandari, S.; Gilbert, R.E.; Stanford, M. Antibiotics versus no treatment for toxoplasma retinochoroiditis. Cochrane Database Syst Rev. 2016, 5. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.J.; Scott, I.U.; Brown, G.C.; Brown, M.M.; Ho, A.C.; Ip, M.S.; Recchia, F.M. Interventions for toxoplasma retinochoroiditis: A report by the American Academy of Ophthalmology. Ophthalmology 2013, 120, 371–378. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hébert, M.; Bouhout, S.; Vadboncoeur, J.; Aubin, M.-J. Recurrent and De Novo Toxoplasmosis Retinochoroiditis following Coronavirus Disease 2019 Infection or Vaccination. Vaccines 2022, 10, 1692. https://doi.org/10.3390/vaccines10101692
Hébert M, Bouhout S, Vadboncoeur J, Aubin M-J. Recurrent and De Novo Toxoplasmosis Retinochoroiditis following Coronavirus Disease 2019 Infection or Vaccination. Vaccines. 2022; 10(10):1692. https://doi.org/10.3390/vaccines10101692
Chicago/Turabian StyleHébert, Mélanie, Soumaya Bouhout, Julie Vadboncoeur, and Marie-Josée Aubin. 2022. "Recurrent and De Novo Toxoplasmosis Retinochoroiditis following Coronavirus Disease 2019 Infection or Vaccination" Vaccines 10, no. 10: 1692. https://doi.org/10.3390/vaccines10101692
APA StyleHébert, M., Bouhout, S., Vadboncoeur, J., & Aubin, M.-J. (2022). Recurrent and De Novo Toxoplasmosis Retinochoroiditis following Coronavirus Disease 2019 Infection or Vaccination. Vaccines, 10(10), 1692. https://doi.org/10.3390/vaccines10101692